Abstract
Cationic amphiphilic drugs (CADs) inhibit phospholipases competitively/uncompetitively. It has also been reported that CADs spontaneously accumulate in acidic organelles and increase their luminal pH, which may lead to deactivation of phospholipid-metabolising enzymes, causing cellular phospholipid accumulation. Recently, however, contradictory results have also been reported in that the luminal pH is not increased by CAD treatment. In this study, we examined whether the lysosomal/late endosomal acidic pH was maintained by vacuolar ATPase (v-ATPase) after treatment with chlorpromazine (CPZ) as a model CAD. The activity of lysosomal protease after CPZ treatment was also measured. Oregon Green–dextran–tetramethylrhodamine conjugate was employed to determine the luminal pH of the lysosomes/late endosomes in RAW264 cells. The luminal pH remained acidic after treatment with CPZ for 23 h, and the lysosomal protease activity was not decreased by 5-min CPZ treatment. Co-treatment with CPZ and bafilomycin A1 (v-ATPase inhibitor) raised the luminal pH. These results suggest that the lysosomal/late endosomal pH is not affected by a 23-h CPZ treatment. In addition, lysosomal enzymes presumably maintain their activity when CPZ accumulates. Our results imply that the pH homeostasis in lysosomes/late endosomes is strictly maintained even after a longer treatment with CADs.
Similar content being viewed by others
Abbreviations
- BAF:
-
Bafilomycin A1
- CAD:
-
Cationic amphiphilic drug
- CLSM:
-
Confocal laser scanning microscopy
- CPZ:
-
Chlorpromazine
- dex:
-
Dextran
- DIPL:
-
Drug-induced phospholipidosis
- HPLC:
-
High-performance liquid chromatography
- LAMP2:
-
Lysosomal-associated membrane protein 2
- MALDI-TOF:
-
Matrix-assisted laser desorption-time of flight
- MON:
-
Monensin sodium salt
- NHE:
-
Na+/H+ exchanger
- OG:
-
Oregon Green 488
- PMSF:
-
Phenylmethylsulfonyl fluoride
- TMR:
-
Tetramethylrhodamine
- v-ATPase:
-
Vacuolar ATPase
References
Abe A, Shayman JA. The role of negatively charged lipids in lysosomal phospholipase A2 function. J Lipid Res. 2009;50:2027–35.
Carlier MB, Laurent G, Tulkens P. In vitro inhibition of lysosomal phospholipases by aminoglycoside antibiotics: a comparative study. Arch Toxicol Suppl. 1984;7:282–5.
Carlsson SR, Roth J, Piller F, Fukuda M. Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Major sialoglycoproteins carrying polylactosaminoglycan. J Biol Chem. 1988;263:18911–9.
Ceh B, Lasic DD. A rigorous theory of remote loading of drugs into liposomes. Langmuir. 1995;11:3356–68.
Corona GL, Cucchi ML, Frattini P, Santagostino G, Schinelli S, Zerbi F, et al. Aspects of amitriptyline and nortriptyline plasma levels monitoring in depression. Psychopharmacol (Berl). 1990;100:334–8.
Fiske CH, Subbarow Y. Phosphorus compounds of muscle and liver. Science. 1929;70:381–2.
Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;226:497–509.
Graves AR, Curran PK, Smith CL, Mindell JA. The Cl−/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes. Nature. 2008;453:788–92.
Hackam DJ, Rotstein OD, Zhang WJ, Demaurex N, Woodside M, Tsai O, et al. Regulation of phagosomal acidification. Differential targeting of Na+/H+ exchangers, Na+/K+-ATPases, and vacuolar-type H+-ATPases. J Biol Chem. 1997;272:29810–20.
Haggie PM, Verkman AS. Unimpaired lysosomal acidification in respiratory epithelial cells in cystic fibrosis. J Biol Chem. 2009;284:7681–6.
Halstead BW, Zwickl CM, Morgan RE, Monteith DK, Thomas CE, Bowers RK, et al. A clinical flow cytometric biomarker strategy: validation of peripheral leukocyte phospholipidosis using Nile red. J Appl Toxicol. 2006;26:169–77.
Hamaguchi R, Kuroda Y, Tanimoto T, Haginaka J. Role of bis(monoacylglycero)phosphate in propranolol binding to phospholipid membranes under acidic conditions as measured by high-performance frontal analysis/capillary electrophoresis. Electrophoresis. 2012;33:3101–6.
Hollemans M, Elferink RO, de Groot PG, Strijland A, Tager JM. Accumulation of weak bases in relation to intralysosomal pH in cultured human skin fibroblasts. Biochim Biophys Acta. 1981;643:140–51.
Hostetler KY, Reasor M, Yazaki PJ. Chloroquine-induced phospholipid fatty liver. Measurement of drug and lipid concentrations in rat liver lysosomes. J Biol Chem. 1985;260:215–9.
Hostetler KY, Reasor MJ, Walker ER, Yazaki PJ, Frazee BW. Role of phospholipase A inhibition in amiodarone pulmonary toxicity in rats. Biochim Biophys Acta. 1986;875:400–5.
Humphries 4th WH, Payne CK. Imaging lysosomal enzyme activity in live cells using self-quenched substrates. Anal Biochem. 2012;424:178–83.
Ishizaki J, Yokogawa K, Hirano M, Nakashima E, Sai Y, Ohkuma S, et al. Contribution of lysosomes to the subcellular distribution of basic drugs in the rat liver. Pharm Res. 1996;13:902–6.
Ishizaki J, Yokogawa K, Ichimura F, Ohkuma S. Uptake of imipramine in rat liver lysosomes in vitro and its inhibition by basic drugs. J Pharmacol Exp Ther. 2000;294:1088–98.
Joshi UM, Kodavanti PR, Coudert B, Dwyer TM, Mehendale HM. Types of interaction of amphiphilic drugs with phospholipid vesicles. J Pharmacol Exp Ther. 1988;246:150–7.
Kodavanti UP, Mehendale HM. Cationic amphiphilic drugs and phospholipid storage disorder. Pharmacol Rev. 1990;42:327–54.
Kornak U, Kasper D, Bösl MR, Kaiser E, Schweizer M, Schulz A, et al. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man. Cell. 2001;104:205–15.
Kornhuber J, Henkel AW, Groemer TW, Städtler S, Welzel O, Tripal P, et al. Lipophilic cationic drugs increase the permeability of lysosomal membranes in a cell culture system. J Cell Physiol. 2010;224:152–64.
Kubo M, Hostetler KY. Mechanism of cationic amphiphilic drug inhibition of purified lysosomal phospholipase A1. Biochemistry. 1985;24:6515–20.
Kuroda Y, Saito M. Prediction of phospholipidosis-inducing potential of drugs by in vitro biochemical and physicochemical assays followed by multivariate analysis. Toxicol In Vitro. 2010;24:661–8.
Lin HJ, Herman P, Lakowicz JR. Fluorescence lifetime-resolved pH imaging of living cells. Cytometry A. 2003;52:77–89.
Ma JY, Ma JK, Weber KC. Fluorescence studies of the binding of amphiphilic amines with phospholipids. J Lipid Res. 1985;26:735–44.
Manders EMM, Verbeek FJ, Aten JA. Measurement of co-localization of objects in dual-colour confocal images. J Microsc. 1993;169:375–82.
Morissette G, Ammoury A, Rusu D, Marguery MC, Lodge R, Poubelle PE, et al. Intracellular sequestration of amiodarone: role of vacuolar ATPase and macroautophagic transition of the resulting vacuolar cytopathology. Br J Pharmacol. 2009;157:1531–40.
Nakamura N, Tanaka S, Teko Y, Mitsui K, Kanazawa H. Four Na+/H+ exchanger isoforms are distributed to Golgi and post-Golgi compartments and are involved in organelle pH regulation. J Biol Chem. 2005;280:1561–72.
Ohgaki R, Matsushita M, Kanazawa H. Localization, ion transport activity, and physiological function of mammalian organellar NHEs. Seikagaku. 2010;82:577–90.
Ohkuma S, Poole B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc Natl Acad Sci U S A. 1978;75:3327–31.
Saito M, Hirai E, Hamaguchi R, Kuroda Y. Cellular phospholipid—accumulation induced by basic drugs does not depend on phospholipid uptake nor neutralization of acidic vesicles. J Pharm Sci & Res. 2011;3:1163–9.
Sharma DK, Choudhury A, Singh RD, Wheatley CL, Marks DL, Pagano RE. Glycosphingolipids internalized via caveolar-related endocytosis rapidly merge with the clathrin pathway in early endosomes and form microdomains for recycling. J Biol Chem. 2003;278:7564–72.
Tietz PS, Yamazaki K, LaRusso NF. Time-dependent effects of chloroquine on pH of hepatocyte lysosomes. Biochem Pharmacol. 1990;40:1419–21.
van Weert AW, Dunn KW, Geuze HJ, Maxfield FR, Stoorvogel W. Transport from late endosomes to lysosomes, but not sorting of integral membrane proteins in endosomes, depends on the vacuolar proton pump. J Cell Biol. 1995;130:821–34.
Walker O, Dawodu AH, Adeyokunnu AA, Salako LA, Alvan G. Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria. Br J Clin Pharmacol. 1983;16:701–5.
Wiström CA, Jones GM, Tobias PS, Sklar LA. Fluorescence resonance energy transfer analysis of lipopolysaccharide in detergent micelles. Biophys J. 1996;70:988–97.
Zheng N, Zhang X, Rosania GR. Effect of phospholipidosis on the cellular pharmacokinetics of chloroquine. J Pharmacol Exp Ther. 2011;336:661–71.
Acknowledgments
This work was financially supported by JSPS KAKENHI Grant Number 21790051. This public sponsor had no role in the design of the study, in its execution or in the decision to submit the manuscript for publication. The authors extend appreciation to Dr Ken-ichi Akagi and Dr Sumie Katayama at the National Institute of Biomedical Innovation for obtaining the transmission electron microscopic images.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hamaguchi, R., Haginaka, J., Tanimoto, T. et al. Maintenance of luminal pH and protease activity in lysosomes/late endosomes by vacuolar ATPase in chlorpromazine-treated RAW264 cells accumulating phospholipids. Cell Biol Toxicol 30, 67–77 (2014). https://doi.org/10.1007/s10565-014-9269-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10565-014-9269-2